Andreas Halvorsen - Viking Global Investors
Holding/activity history for Eli Lilly & Co. (LLY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.94 | SEC | ||
| 2025 Q2 | 416,918 | 0.94 | Buy | 0.94 | $779.53 | $325,000,089 | SEC |
| 2024 Q4 | 0 | 0.00 | Sell 100.00% | 0.49 | SEC | ||
| 2024 Q3 | 152,038 | 0.49 | Add 5.45% | 0.03 | $885.94 | $134,696,546 | SEC |
| 2024 Q2 | 144,175 | 0.50 | Add 7.11% | 0.03 | $905.38 | $130,533,162 | SEC |
| 2024 Q1 | 134,608 | 0.39 | Reduce 2.97% | <0.01 | $777.96 | $104,719,640 | SEC |
| 2023 Q4 | 138,728 | 0.30 | Buy | 0.30 | $582.92 | $80,867,326 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 2.16 | SEC | ||
| 2016 Q3 | 6,092,264 | 2.16 | Reduce 35.03% | 1.11 | $80.26 | $488,965,000 | SEC |
| 2016 Q2 | 9,377,395 | 3.18 | Reduce 20.29% | 0.77 | $78.75 | $738,470,000 | SEC |
| 2016 Q1 | 11,763,778 | 3.79 | Buy | 3.79 | $72.01 | $847,110,000 | SEC |
| 2015 Q2 | 0 | 0.00 | Sell 100.00% | 0.43 | SEC | ||
| 2015 Q1 | 1,398,711 | 0.43 | Buy | 0.43 | $72.65 | $101,616,000 | SEC |
| 2012 Q4 | 0 | 0.00 | Sell 100.00% | 2.23 | SEC | ||
| 2012 Q3 | 4,939,200 | 2.23 | Add 41.43% | 0.65 | $47.41 | $234,167,000 | SEC |
| 2012 Q2 | 3,492,300 | 1.70 | Buy | 1.70 | $42.91 | $149,854,000 | SEC |